Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 7, 2023, AN2 Therapeutics, Inc. (the "Company") held its 2023 annual meeting of stockholders (the "Annual Meeting"). Present at the beginning of the Annual Meeting via proxy were the holders of 16,610,548 shares of common stock of the Company, representing 85.50% of the 19,426,452 shares of common stock outstanding as of the close of business on April 19, 2023, the record date for the Annual Meeting, and constituting a quorum for the transaction of business.

At the Annual Meeting, the Company's stockholders voted on two proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 26, 2023. The following is a brief description of each matter voted upon and the certified results, including the number of votes cast for or against each matter and, if applicable, the number of votes withheld, abstentions and broker non-votes with respect to each matter.



    1.   To elect the nominees Kabeer Aziz, Gilbert Lynn Marks, M.D. and Rob
         Readnour, Ph.D. as Class I directors until the Company's 2026 annual
         meeting of stockholders or until their respective successors have been
         elected or appointed. The voting results were as follows:



                                              Votes         Broker
Name                        Votes For       Withheld       Non-Votes         Total
Kabeer Aziz                  14,783,208       747,428       1,079,912       16,610,548
Gilbert Lynn Marks, M.D.     14,781,503       749,133       1,079,912       16,610,548
Rob Readnour, Ph.D.          14,607,802       922,834       1,079,912       16,610,548



    2.   To ratify the appointment of PricewaterhouseCoopers LLP as the Company's
         independent registered public accounting firm for the fiscal year ending
         December 31, 2023. The voting results were as follows:



Votes For    Votes Against   Abstentions     Total
16,558,919      51,629            0        16,610,548

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses